STRATA Skin Sciences Announces Appointment of New VP of Marketing
August 02 2021 - 8:00AM
STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the
“Company”), a medical technology company dedicated to developing,
commercializing, and marketing innovative products for the
treatment of dermatologic conditions, today announced the
appointment of Brent Cowgill as Vice President of Marketing.
“We are delighted to welcome Mr. Cowgill to the
STRATA team,” said Robert J. Moccia, Chief Executive Officer of
STRATA. “His extensive background in healthcare sales and marketing
will prove to be invaluable in the execution of our strategic
marketing efforts to both customers and dermatologists. One of our
highest priorities at STRATA is driving superior commercial
execution and we believe that Brent is the ideal leader to help us
achieve and maintain this goal.”
Mr. Cowgill has over 20 years of healthcare
sales and marketing experience. Prior to joining STRATA he managed
Vantage Marketing, a healthcare consulting firm which he founded 9
years ago, that focused on commercializing prescription treatments
in the U.S. market. Brent has held various commercial positions at
both Fortune 500 and emerging healthcare companies. His roles and
responsibilities, while varied, stayed focused on supporting the
strategic and commercial efforts at companies such as Graceway
Pharmaceuticals, Bioglan Pharmaceuticals, and Bristol Myers Squibb.
Mr. Cowgill holds a B.S. degree in Marketing from Bowling
Green State University.
“I am very excited to join the STRATA team,”
said Mr. Cowgill. “I look forward to helping STRATA expand its
presence within the dermatology market while building upon XTRAC's
commercial success as the market’s leading excimer laser technology
used to treat several chronic skin conditions that afflict millions
of people worldwide.”
About STRATA Skin Sciences,
Inc.STRATA Skin Sciences is a medical technology company
in dermatology dedicated to developing, commercializing and
marketing innovative products for the treatment of dermatologic
conditions. Its products include the XTRAC® excimer laser and
VTRAC® lamp systems utilized in the treatment of psoriasis,
vitiligo and various other skin conditions.
The Company’s proprietary XTRAC excimer laser
delivers a highly targeted therapeutic beam of UVB light to treat
psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma,
diseases which impact over 31 million patients in the United States
alone. The technology is covered by multiple patents.
STRATA’s unique business model leverages
targeted Direct to Consumer (DTC) advertising to generate awareness
and utilizes its in-house call center and insurance advocacy teams
to increase volume for the Company’s partner dermatology
clinics.
Investor Contact |
|
|
Leigh Salvo |
|
|
(415) 937-5404 |
|
|
ir@strataskin.com |
|
|
Strata Skin Sciences (NASDAQ:SSKN)
Historical Stock Chart
From Apr 2024 to May 2024
Strata Skin Sciences (NASDAQ:SSKN)
Historical Stock Chart
From May 2023 to May 2024